SCHEMBL16399337

SCHEMBL16399337

N#Cc1[nH]nnc1-c1cccc(OCc2ccc(C(F)(F)F)c(C(F)(F)F)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 9/20 0.38
▸ NR1H3 Q13133 6/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PPARG P37231 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NCOA2 Q15596 1/20 0.36
▸ NCOA1 Q15788 1/20 0.36
▸ CYP11B1 P15538 3/20 0.36
▸ PGR P06401 1/20 0.36
▸ AR P10275 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ MRGPRX4 Q96LA9 1/20 0.36
▸ USP7 Q93009 1/20 0.35
▸ NAAA Q02083 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ NR4A2 P43354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18006409 0.91 NR1H2 (0.40) NR1H2NR1H3KDM4EMEN1ALDH1A1
SCHEMBL18004043 0.91 IDO1 (0.41) NR1H2NR1H3CYP11B1CYP11B2MRGPRX4
SCHEMBL18004294 0.87 PTGDR2 (0.32) NR1H2KDM4EMEN1ALDH1A1MAPT
SCHEMBL18003993 0.86 NR4A2 (0.50) NR1H2NR1H3MAPTMRGPRX4MAOB
SCHEMBL18004436 0.85 NR4A2 (0.41) NR1H2NR1H3KDM4EMEN1ALDH1A1
SCHEMBL18004906 0.84 CYP11B1 (0.40) KDM4EMEN1ALDH1A1MAPTPPARG
SCHEMBL16399407 0.84 CYP11B1 (0.39) NR1H2NR1H3KDM4EMEN1ALDH1A1
SCHEMBL18004689 0.84 MRGPRX4 (0.47) NR1H2NR1H3MAPTMRGPRX4MAOB
SCHEMBL18003995 0.84 IGF1R (0.43) KDM4EMEN1ALDH1A1MAPTPPARG
SCHEMBL16399235 0.84 NR1H2 (0.42) NR1H2NR1H3KDM4EPGRAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4570313-A2 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2025-06-18 — — EP claimed
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 — — EP claimed
US-10626095-B2 Cyanotriazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-04-21 — — US claimed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 — — US claimed
EP-4570313-A2 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2025-06-18 — — EP disclosed
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 — — EP disclosed
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 — — EP disclosed
US-10626095-B2 Cyanotriazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-04-21 — — US disclosed
US-10626095-B2 Cyanotriazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-04-21 — — US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 — — US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 — — US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 — — US disclosed
EP-3022199-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2016-05-25 — — EP disclosed
WO-2015008872-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-01-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10626095-B2 Cyanotriazole compounds CS, PC, ACAT1 NR1H2 552/4885NR1H3 498/4885KDM4E 2681/4885
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS CS, PC, ACAT1 NR1H2 552/4885NR1H3 498/4885KDM4E 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback